pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,989 catalysts · 5,347 phase readout · 2,296 8k filing · 343 pdufa · 257 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 23 catalysts2026-08-04: 13 catalysts2026-08-05: 18 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 1 catalyst2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,296
  • pdufa343
  • earnings257
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›NOT_YET_RECRUITINGphase readoutNCT07264140: Assessing and Improving Misuse of Inhalers in COPD Outpatients

Sponsor: Hôpital Fribourgeois. Phase: NA. Conditions: Chronic Obstructive Pulmonary Disease (COPD)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07038889: Overground Virtual Reality (VR) Gait Rehabilitation for Traumatic Brain Injury (TBI)

Sponsor: Indiana University. Phase: NA. Conditions: Traumatic Brain Injury, Stroke, Gait Training

full page →ctgov ↗
›RECRUITINGphase readoutNCT07471789: Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL).

Sponsor: Gyala Therapeutics. Phase: PHASE1. Conditions: Acute Myeloblastic Leukaemia, Leukemia, T-Cell

full page →ctgov ↗
›RECRUITINGphase readoutNCT06373289: Pulmonary Hypertension and Oxygen Saturation Targeting in Preterm Infants

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Bronchopulmonary Dysplasia, Pulmonary Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT06634368: Pilot Study of Hospital GamePlan4Care

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Caregivers

full page →ctgov ↗
›SUSPENDEDphase readoutNCT07285668: Prophylactic TCRaB+ and CD19+ Depleted Donor Lymphocyte Infusion After Allogeneic Stem Cell Transplant in High-Risk Patients With Hematologic Malignancies

Sponsor: University of Wisconsin, Madison. Phase: NA. Conditions: Hematologic Malignancies

full page →ctgov ↗
›COMPLETEDphase readoutNCT07522268: Laser Pulpotomy: a Modern-non Pharmacological Alternate to Ferric Sulphate Pulpotomy

Sponsor: Shaheed Zulfiqar Ali Bhutto Medical University. Phase: PHASE3. Conditions: Pulpotomy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07554768: Neoadjuvant Radio-immunotherapy Versus Immunotherapy Alone for Locally Advanced HNSCC

Sponsor: Chen Chunyan. Phase: PHASE2. Conditions: Head and Neck Squamous Cell Carcinoma, Locally Advanced Head and Neck Squamous Cell Carcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07389850: Evaluation of the Evolution of Proprioceptive Reweighting Abilities Following Anterior Cruciate Ligament Reconstruction Surgery

Sponsor: University Hospital, Brest. Phase: NA. Conditions: Anterior Cruciate Ligament Rupture With Ligamentoplasty

full page →ctgov ↗
›RECRUITINGphase readoutNCT07404774: Hemorrhoid Suture Mucopexy Combined With Laser Hemorrhoidoplasty

Sponsor: National and Kapodistrian University of Athens. Phase: . Conditions: Haemorrhoid, Haemorrhoidal Bleeding, Anorectal Surgeries, Anorectal Diseases

full page →ctgov ↗
›RECRUITINGphase readoutNCT04624490: Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

Sponsor: Mario Castro, MD, MPH. Phase: PHASE1. Conditions: Asthma, COPD, Interstitial Lung Disease, Cystic Fibrosis, Pulmonary Hypertension, Pulmonary Infection, Other Lung Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04685590: Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD) Study

Sponsor: Washington University School of Medicine. Phase: PHASE2. Conditions: Alzheimer Disease, Early Onset, Mild Cognitive Impairment

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07256197: PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis

Sponsor: Beijing Anzhen Hospital. Phase: PHASE3. Conditions: Aortic Stenosis, Calcific

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06136897: Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Malignant Solid Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07478497: 30 Day Insulin Balance Metabolic Health Optimization Protocol

Sponsor: Efforia, Inc. Phase: NA. Conditions: Insulin

full page →ctgov ↗
›RECRUITINGphase readoutNCT05769010: Study of SHR-A1811 in HER2-expression Advanced Breast Cancer With Brain Metastases

Sponsor: Henan Cancer Hospital. Phase: PHASE2. Conditions: Metastatic Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07405710: Use of the Electronic Medical Record to Screen Code Status Preference Using Death Language

Sponsor: Rutgers, The State University of New Jersey. Phase: NA. Conditions: Code Status Discussions With Medical In-patients

full page →ctgov ↗
›RECRUITINGphase readoutNCT06376513: Evaluation of Penile Prosthesis Pump Manipulation

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Penile Prosthesis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06325020: Objective Risk Assessment in Patients With Possible Anginal Chest Pain Using Leading Technology

Sponsor: University of Edinburgh. Phase: . Conditions: Angina, Stable, Coronary Artery Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07518420: Clinical Efficacy Evaluation of Chaizhi Hewei Decoction in the Treatment of Non-Erosive Reflux Disease With Liver-Stomach Disharmony Syndrome

Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences. Phase: NA. Conditions: Non-erosive Reflux Disease (NERD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07460960: TRIal of STatin Therapy Effect on Androgen Status and Erectile functioN in Men

Sponsor: Lomonosov Moscow State University Medical Research and Educational Center. Phase: PHASE2. Conditions: Erectile Dysfunction Due to Arterial Disease, Atheroscleroses, Erectile Disfunction, Endothelial Dysfunction, Androgen Profile, Testosterone

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06973720: A Phase 2b Study to Evaluate the Efficacy and Safety of Once-Monthly MET097 in Adults With Obesity or Overweight

Sponsor: Metsera, a wholly owned subsidiary of Pfizer. Phase: PHASE2. Conditions: Obesity, Overweight or Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT05195138: Mindfulness-Based Diabetes Education for Adults With Elevated Diabetes Distress

Sponsor: University of Alabama at Birmingham. Phase: NA. Conditions: Type 2 Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT07231458: A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies

Sponsor: Abalos Therapeutics GmbH. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07476248: The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

Sponsor: Assiut University. Phase: . Conditions: Diabetic Nephropathy, Dyslipidemia

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06204614: Drug Screening Using IMD in Bladder Cancer

Sponsor: Brigham and Women's Hospital. Phase: EARLY_PHASE1. Conditions: Muscle Invasive Bladder Urothelial Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07531706: Cortical Tracking of Speech in the First Year of Life

Sponsor: IRCCS Eugenio Medea. Phase: . Conditions: Language Development, Language Development Disorders, Infant Development, Infant Developmental Assessment

full page →ctgov ↗
›COMPLETEDphase readoutNCT06758206: Flywheel Resistance Training and Traditional Resistance Training in Older Women With Sedentary Behaviors

Sponsor: Federal University of Vicosa. Phase: NA. Conditions: Depressive Symptoms, Physical Function, Executive Function, Resistance Training

full page →ctgov ↗
›COMPLETEDphase readoutNCT07496684: Application and Evaluation of Vision-LSTM Modeling in Diagnostic Ultrasound Imaging of TI-RADS Category 4b Thyroid Nodules

Sponsor: Ma Zhe. Phase: . Conditions: Thyroid Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT03837184: Single-Dose Gene Replacement Therapy Using for Patients With Spinal Muscular Atrophy Type 1 With One or Two SMN2 Copies

Sponsor: Novartis Gene Therapies. Phase: PHASE3. Conditions: Spinal Muscular Atrophy Type I

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07583784: Abbreviated Antithrombotic Therapy After PCI in Patients With AF and AMI

Sponsor: Chonnam National University Hospital. Phase: NA. Conditions: Myocardial Infarction (MI), ST-Segment Elevation Myocardial Infarction(STEMI), NSTEMI - Non-ST-Segment Elevation Myocardial Infarction, AF - Atrial Fibrillation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07319533: Clinical Trial Investigating the Effect of Exosomes as a Complementary Treatment in Severe to Moderate Erectile Dysfunction

Sponsor: Labbafinejad Medical Center. Phase: PHASE2. Conditions: Erectile Dysfunction, Erectile Dysfunction Associated With Type 2 Diabetes Mellitus, Erectile Dysfunction Due to Arterial Disease, Erectile Dysfunction Due to Arterial Insufficiency, Erectile Dysfunction Due to General Medical Condition, Erectile Dysfunction Due to Neuropathy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07578233: Multiparametric MRI for Bladder Cancer: Validation of VI-RADS for the Detection of Muscle Invasive Bladder Cancer

Sponsor: Ain Shams University. Phase: . Conditions: Multiparametric, Magnetic Resonance Imaging, Validation, Vesical Imaging Reporting and Data System (VI-RADS), Muscle Invasive Bladder Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06971952: Tuberculosis in Rural and Malnourished Populations

Sponsor: University of Virginia. Phase: NA. Conditions: Tuberculosis (TB), Undernutrition

full page →ctgov ↗
›COMPLETEDphase readoutNCT04522947: Modifiable Predictors of Neural Vulnerabilities for Obesity

Sponsor: University of Nebraska Lincoln. Phase: NA. Conditions: Obesity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06426147: L-citrulline to Improve Adverse Outcomes in Admitted Children (EChiLiBRiST, Clinical Trial 2, Inpatients)

Sponsor: Barcelona Institute for Global Health. Phase: NA. Conditions: Infectious Disease, Infections, Child, Only

full page →ctgov ↗
›RECRUITINGphase readoutNCT07345247: RAdiation SEgmentectomy With REsin Microspheres (RASEREM) Study

Sponsor: Ankara University. Phase: . Conditions: Liver Cancer, Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT06532747: Redefining BMI: The Body, Mind, and Inflammation Trial

Sponsor: Virginia Commonwealth University. Phase: NA. Conditions: Obesity, Adiposity

full page →ctgov ↗
›RECRUITINGphase readoutNCT03520647: Haplo-identical Transplantation for Severe Aplastic Anemia, Hypo-plastic MDS and PNH Using Peripheral Blood Stem Cells and Post-transplant Cyclophosphamide for GVHD Prophylaxis

Sponsor: National Heart, Lung, and Blood Institute (NHLBI). Phase: PHASE2. Conditions: Severe Aplastic Anemia (SAA), Hypo-Plastic Myelodysplastic Syndrome (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06645847: Targeting Aging With a Ketone Ester for Function in Frailty

Sponsor: Buck Institute for Research on Aging. Phase: NA. Conditions: Frail Elderly, Aging, Immune Function, Muscle Function

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07031947: The Effect of Core Stabilization Exercises Applied With Virtual Reality-Based Telerehabilitation in the Treatment of Chronic Low Back Pain

Sponsor: Istanbul University. Phase: NA. Conditions: Low Back Pain, Low Back Pain, Mechanical, Low Back Pain and Core Muscle, Core Stabilization Exercise Therapy

full page →ctgov ↗
›RECRUITINGphase readoutNCT07459647: A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Sponsor: MapLight Therapeutics. Phase: PHASE2. Conditions: Schizophrenia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07245849: Pericardial Imaging Study

Sponsor: Ottawa Heart Institute Research Corporation. Phase: PHASE3. Conditions: Pericarditis

full page →ctgov ↗
›TERMINATEDphase readoutNCT04615949: Cannabidiol in Patients With COVID-19 and Cardiovascular Disease or Risk Factors

Sponsor: Cardiol Therapeutics Inc.. Phase: PHASE2. Conditions: COVID-19, Cardiovascular Diseases, Cardiovascular Risk Factor

full page →ctgov ↗
›COMPLETEDphase readoutNCT07139158: Muscle Oxygenation in Patellofemoral Pain

Sponsor: Ankara Medipol University. Phase: . Conditions: Patellofemoral Pain, PFP

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06008158: Evaluation of a Once Per Day Regimen of Accelerated Partial Breast Irradiation for Improved Breast Appearance in Pts w/Low Risk, Hormone Responsive Brst Ca

Sponsor: City of Hope Medical Center. Phase: PHASE2. Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Estrogen Receptor-Positive Breast Carcinoma, HER2-Negative Breast Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT06948058: Clinical Research Evaluating Smoking Cessation With E-Cigarettes and Nicotine Therapy

Sponsor: Brown University. Phase: NA. Conditions: Smoking Cessation, Obesity and Obesity-related Medical Conditions

full page →ctgov ↗
›RECRUITINGphase readoutNCT04791748: Virtual Reality in Children With and Without Vestibular Deficits

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Vestibular Diseases

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07543848: A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Sponsor: Chongqing University Cancer Hospital. Phase: PHASE2. Conditions: Rectal Neoplasms, Rectal Adenocarcinoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07409948: Multicomponent Care for Aromatase Inhibitor-Related Musculoskeletal Symptoms

Sponsor: Addis Ababa University. Phase: NA. Conditions: Breast Neoplasms, Musculoskeletal Pain, Arthralgia, Musculoskeletal Diseases, Pain, Fatigue Syndrome, Chronic

full page →ctgov ↗
← prev
page 85 of 160
next →